Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele H Potashman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Infection and Drug Resistance|February 13, 2016
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureusMichele H Potashman, Michael Stokes, Jieruo Liu, et al.
Journal of Medical Economics|April 25, 2014
Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphomaGregory B Kruse, Michele H Potashman, Spyros Stavrakas, et al.
Cerebellum (London, England)|December 10, 2022
Ataxia Rating Scales Reflect Patient Experience: an Examination of the Relationship Between Clinician Assessments of Cerebellar Ataxia and Patient-Reported OutcomesMichele H Potashman, Miranda L Mize, Melissa W Beiner, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|November 15, 2024
Determinants of health-related quality of life of patients with focal epilepsy: A systematic literature reviewPamela Engelhart, Caleb Marcin, Jason Lerner, et al.
Journal of the American College of Surgeons|September 11, 2015
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative IleusStephanie R Earnshaw, Teresa L Kauf, Cheryl McDade, et al.
Developmental Medicine and Child Neurology|January 13, 2026
Patient outcomes in KCNQ2 developmental and epileptic encephalopathyGrant Maclaine, Michele H Potashman, Deepshikha Pawar, et al.
Neurology and Therapy|September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying TherapiesSamuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
Neurology and Therapy|January 13, 2025
Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar AtaxiaMichele H Potashman, Evan Popoff, Lauren C Powell, et al.
Neurology and Therapy|May 30, 2024
Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc AnalysisGilbert J L'Italien, Evangelos K Oikonomou, Rohan Khera, et al.
BMJ Open|January 25, 2018
Resource utilisation and costs in predementia and dementia: a systematic review protocolFilipa Landeiro, Helena Wace, Isaac Ghinai, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Infection and Drug Resistance|February 13, 2016
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureusMichele H Potashman, Michael Stokes, Jieruo Liu, et al.
Journal of Medical Economics|April 25, 2014
Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphomaGregory B Kruse, Michele H Potashman, Spyros Stavrakas, et al.
Cerebellum (London, England)|December 10, 2022
Ataxia Rating Scales Reflect Patient Experience: an Examination of the Relationship Between Clinician Assessments of Cerebellar Ataxia and Patient-Reported OutcomesMichele H Potashman, Miranda L Mize, Melissa W Beiner, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|November 15, 2024
Determinants of health-related quality of life of patients with focal epilepsy: A systematic literature reviewPamela Engelhart, Caleb Marcin, Jason Lerner, et al.
Journal of the American College of Surgeons|September 11, 2015
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative IleusStephanie R Earnshaw, Teresa L Kauf, Cheryl McDade, et al.
Developmental Medicine and Child Neurology|January 13, 2026
Patient outcomes in KCNQ2 developmental and epileptic encephalopathyGrant Maclaine, Michele H Potashman, Deepshikha Pawar, et al.
Neurology and Therapy|September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying TherapiesSamuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
Neurology and Therapy|January 13, 2025
Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar AtaxiaMichele H Potashman, Evan Popoff, Lauren C Powell, et al.
Neurology and Therapy|May 30, 2024
Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc AnalysisGilbert J L'Italien, Evangelos K Oikonomou, Rohan Khera, et al.
BMJ Open|January 25, 2018
Resource utilisation and costs in predementia and dementia: a systematic review protocolFilipa Landeiro, Helena Wace, Isaac Ghinai, et al.
Pageof 2